Hong Chang

CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma

Suzanne Trudel, Zhihua Li, Ellen Wei et al. · Blood · 2004 · 288 citations · Full text

p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation

Hong Chang, Connie Qi, Qi-Long Yi et al. · Blood · 2004 · 202 citations · Full text

The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant

Hong Chang, Stephen R. Sloan, Dan Li et al. · British Journal of Haematology · 2004 · 194 citations · Full text

Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13

Donna Reece, Kevin Song, Tommy Fu et al. · Blood · 2009 · 183 citations

Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome

Hong Chang, Joseph Brandwein, Qilong Yi et al. · Leukemia Research · 2004 · 170 citations

Inflammation, Extramedullary Infiltrates, Hematological Malignancy +9